The grant you were counting on didn’t get funded. You need more than the angels will put up and the VCs think you’re too risky or too early. Where else to turn? Edwin K. Hunter, who is on the board of multiple foundations, including the Salk Institute, explains why every life science startup should pursue program-related investments (PRIs) as part of their fundraising strategy.